Author: OurCrowd

Eye-opening innovation: Top 10 incredible Israeli advances in vision

The Startup Nation is known for its eye opening innovation — literally speaking, that is. Israel is home to a growing medical device industry. It’s developed an advanced infrastructure of medical and paramedical research as well as bio-engineering capabilities. Israeli researchers have provided an impressive number of medical advances and copious contributions across the various branches of the medical industry and the field of vision is no exception. Israeli scientists have been consistently a dominant force in developing innovative technologies to help transform the lives of the world’s blind and visually impaired. World Sight Day, an annual day of awareness held on the second Thursday of October to focus global attention on blindness and vision impairment, falls out this week on October 10th. As writer Abigail Klein Leichman points out in ISRAEL21c, an online news magazine covering 21st century Israel, this is the “perfect opportunity to present some of the amazing advances coming out of Israel for treating medical conditions of the eye.” The ISRAEL21c article lists a range of innovations that dramatically improve eyesight or the quality of life for people with vision impairments. The various technologies listed address a wide range of visual impairments,...

Read More

The media wants to know about crowdfunding: OurCrowd’s Jon Medved makes the rounds

On Sunday, OurCrowd’s CEO Jon Medved commenced a three-week tour across the US, accompanied by a coterie of OurCrowd portfolio companies, including Webydo and Parko (you’ll have to register to see more info about the companies we’re investing in currently). Jon’s trip began with an appearance with interviews with Bloomberg’s Pimm Fox and the CBC’s Lang and O’Leary Exchange. Bloomberg’s Pimm Fox talks crowdfunding with OurCrowd’s Jon Medved Jon Medved talks with Lang and O’Leary about how OurCrowd chooses investments Read the whole article   Meet up with Jon on his U.S. tour To find out where Jon is appearing next and meeting with investors, check out his upcoming...

Read More